novel treatment strategies in low-risk mds: challenges and emerging therapies
Published 2 years ago • 395 plays • Length 18:14Download video MP4
Download video MP3
Similar videos
-
18:42
novel treatment strategies in low-risk mds: case study
-
14:55
novel treatment strategies in low-risk mds: q&a
-
24:04
my approach to mds management
-
33:47
my approach to mds management
-
1:34
managing adverse events with novel therapies in lower-risk mds
-
4:12
novel therapies in low-risk mds
-
52:20
acute myeloid leukemia: incorporating novel treatment approaches into clinical pathways
-
19:11
novel agents and combination therapies in myelofibrosis
-
18:29
aml treatment challenges who, when, and how
-
10:11
novel agents and treatment strategies in myelodysplastic syndromes
-
1:25
novel strategies for treating cytopenia in mds
-
23:20
therapy for “early mf”: pros and cons
-
1:38
novel treatment options for lr-mds and the importance of clinical trials in this space
-
17:29
somatic mutations of rna splicing machinery in mds
-
14:05
myelofibrosis: emerging jak2 inhibitor combination treatment strategies
-
20:58
new findings and improved outcomes in the treatment of aml
-
2:43
novel therapies in the future of mds treatment
-
2:04
state-of-the-art treatment for hr-mds
-
1:41
novel therapies for high-risk mds